Risk factors and therapeutic response in Chinese patients with peptic ulcer disease

World Journal of Gastroenterology

Volumn 16, Issue 16, 2010, Pages 2017-2022

  Lee, Shou Wu ^a   Chang, Chi Sen ^a   Lee, Teng Yu ^a   Yeh, Hong Zen ^a   Tung, Chun Fang ^a   Peng, Yen Chun ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Epidemiology; Peptic ulcer disease; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CIMETIDINE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHINESE; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFICACY; DRUG USE; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE; SMOKING; STOMACH ULCER; TAIWAN; TREATMENT RESPONSE;

EID: 77951970647     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i16.2017     Document Type: Article

References (20)

1. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009; 29: 938-946
2. Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 2007; 41: 548-558
3. Rosenstock S, JÃ̧rgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 2003; 52: 186-193
4. Yuan Y, Padol IT, Hunt RH. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 80-89
5. Dore MP, Graham DY. Pathogenesis of duodenal ulcer disease: the rest of the story. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 97-107
6. Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 1996; 6: 489-504
7. Pérez-Aisa MA, Del Pino D, Siles M, Lanas A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 21: 65-72
8. Wu CY, Wu CH, Wu MS, Wang CB, Cheng JS, Kuo KN, Lin JT. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol 2009; 7: 427-431
9. Sonnenberg A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 Suppl 2: 3-12
10. Harewood GC, Holub JL, Lieberman DA. Biopsy specimen acquisition in patients with newly diagnosed peptic ulcer disease as determined from a national endoscopic database. Gastrointest Endosc 2004; 59: 664-669
11. Watanabe Y, Kurata JH, Kawamoto K, Kawai K. Epidemiological study of peptic ulcer disease among Japanese and Koreans in Japan. J Clin Gastroenterol 1992; 15: 68-74
12. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA. Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study. Gut 1990; 31: 989-992
13. Graham DY, Klein PD, Opekun AR, Boutton TW. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 1988; 157: 777-780
14. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186
15. Arkkila PE, Seppälä K, Kosunen TU, Sipponen P, Mäkinen J, Rautelin H, Färkkilä M. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. Eur J Gastroenterol Hepatol 2005; 17: 93-101
16. Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, Chan AO, Lai CL, Wong J. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-2038
17. Yeomans ND. New data on healing of nonsteroidal antiinflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Am J Med 1998; 104: 56S-61S; discussion 79S-80S
18. Meneghelli UG, Zaterka S, de Paula Castro L, Malafaia O, Lyra LG. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil. Am J Gastroenterol 2000; 95: 62-66
19. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in pepticulcer disease: a meta-analysis. Lancet 2002; 359: 14-22
20. Murakami K, Okimoto T, Kodama M, Tanahashi J, Yasaka S, Inoue K, Uchida M, Anan J, Mizukami K, Abe T, Watada M, Fujioka T. Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population. J Gastroenterol 2009; 44 Suppl 19: 40-43